Lymphatic vessel density as a prognostic marker in clinical stage i endocervical adenocarcinoma

International Journal of Gynecological Pathology

Volumn 29, Issue 4, 2010, Pages 386-393

  Saad, Reda S ^a,b   Ismiil, Nadia ^a   Ghorab, Zeina ^a   Nofech Mozes, Sharon ^a   Dubé, Valérie ^a   Covens, Allan ^a   Khalifa, Mahmoud A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY D2-40; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; DIAGNOSTIC USE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH VESSEL; LYMPHANGIOGENESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 77954116646     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181c3cd47     Document Type: Article

References (43)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1990;82:4-6.
3. Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphan-giogenesis as well as angiogenesis. J Exp Med 2002;196: 1497-506.
4. Lee JS, Choi YD, Lee JH, et al. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth. Gyn Oncol 2004;95:523-9.
5. Vieira SC, Silva BB, Pinto GA, et al. CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract 2005;201:313-8.
6. Cheng WF, Lee C, Chu J. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999;85:651-7.
7. Witte MH, Bernas MJ, Martin CP, et al. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech 2001;55:122-45.
8. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-34.
9. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
10. Fidler IJ. Molecular biology of cancer: invasion and metastasis. In: DeVita VT Jr, Hellman S, Rosenburgh SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: Lippincott-Raven; 2001:135-53.
11. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. Cancer 1992;69:1750-8.
12. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002;16: 922-34.
13. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001;7:462-8.
14. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003;9:250-6.
15. Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951-60.
16. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphan-giogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62:1315-20.
17. Kurahara H, Takao S, Maemura K, et al. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res 2004;10:8413-20.
18. Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 2001;21:2351-5.
19. Gambos Z, Xu X, Chu CS, et al. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005;11:8364-71.
20. Longatto-Filho A, Pinheiro C, Pereira SMM, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in preinvasive and invasive lesions of the uterine cervix. Gynecol Oncol 2007;107:45-51.
21. Sleeman JP, Krishnan J, Kirkin V, et al. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech 2001;55:61-9.
22. Kahn HJ, Marks A. A new monoclonal antibody, D2-40 for detection of lymphatic invasion in primary tumors. Lab Invest 2002;82:1255-7.
23. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer. Gynecol Oncol 2004;92:525-9.
24. Wells M, Ostor AG, Crum CP, et al. Tumors of the Uterine Cervix. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics: Tumors of the Breast and Female Genital Organs: World Health Organization Classification of Tumors. Lyon: IARC Press; 2003:260-83; chapter 5.
25. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
26. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83.
27. Padera TP, Kadambi A, Di Thomaso E, et al. Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 2002;296:1883-6.
28. Van Trappen PO, Pepper MS. Lymphatic dissemination of tumor cells and the formation of micrometastases. Lancet Oncol 2002;3:44-52.
29. Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynecological cancers. Angiogenesis 2005;6:1-9.
30. Sleeman JP. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent results. Cancer Res 2000;157: 55-81.
31. Saad RS, Kordunsky L, Liu YL, et al. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 2006;19:1317-23.
32. Urabe A, Matsumoto T, Kimura M, et al. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 2006; 49:493-7.
33. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005; 58:202-6.
34. Chargui R, Damak T, Khomsi F, et al. Prognostic factors and clinicopathologic characteristics of invasive adeno-carcinoma of the uterine cervix. Am J Obstet Gynecol 2006;194: 43-8.
35. Kainz C, Gitsch G, Tempfer C, et al. Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB. Anticancer Res 1994;14:2245-8.
36. Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25.
37. Tsai CS, Lai CH, Wang CC, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999; 75:328-33.
38. Weidner N. Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998; 184:119-22.
39. Lee JS, Kim HS, Jung JJ, et al. Expression of vascular endothelial growth factors in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erB-2 protein expression. Gynecol Oncol 2002;85:469-75.
40. Tjalma WA, Weyler JJ, Bogers JJ, et al. The importance of biological factors (bcl-2, bax, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2001;97:223-30.
41. Di Leo S, Caschetto S, Garozzo G, et al. Angiogenesis as a prognostic factor in cervical carcinoma. Eur J Gynaecol Oncol 1998;19:158-62.
42. Tjalma W, Van Marck V, Weyler J, et al. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer 1998;78:170-4.
43. Hirakawa T, Kamura T, Kaku T, et al. Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1999;74:369-74.